Seikagaku: Confirmatory letter.
Seikagaku: Half Year Report - Term 79 (2024/04/01 - 2025/03/31)
Seikagaku: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)
Seikagaku: Change Report
Seikagaku: Notice regarding approval of the endoscopic submucosal injection material “MuCoUP” in China and the conclusion of a sales agency agreement with Tozai Trading Co., Ltd.
Seikagaku: Notice regarding organizational changes and personnel changes
Seikagaku: Change report (exemption share certificates, etc.)
Seikagaku: Change Report
Seikagaku: March 2025 first quarter financial statement announcement [Japan Standard] (consolidated)
Seikagaku: Announcements of individual stocks related to personnel changes.
Change report (exemption share certificates, etc.)
Seikagaku: Announcements of individual stocks regarding the completion of payment for the disposal of treasury stock as restricted stock compensation.
Seikagaku: Internal Control Report - 78th term (April 1, 2023 - March 31, 2024)
Seikagaku: Confirmatory letter.
Seikagaku: Securities report - 78th period (April 1, 2023 - March 31, 2024)
Seikagaku: Report on Corporate Governance, June 25, 2023.
Seikagaku: Interim report
Seikagaku: Announcements of individual stocks regarding the scheduled submission date of securities reports.
Seikagaku: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.
Seikagaku: Announcements of individual stocks related to personnel changes.
No Data
No Data